MarketCapTrends
CRBP
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare

Corbus Pharmaceuticals Holdings, Inc. Total Liabilities 2015–2022

Corbus Pharmaceuticals Holdings, Inc. annual/quarterly total liabilities history from 2015 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Corbus Pharmaceuticals Holdings, Inc. total liabilities for the quarter ending December 31, 2022 were 33.3M, a 13.72% decrease year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2022 were 33.3M, a 13.72% decrease from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2021 were 38.6M, a 32.27% decrease from 2020.
  • Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2020 were 57.0M, a 32.65% increase from 2019.
  • Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2019 were 43.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Corbus Pharmaceuticals Holdings, Inc. Annual Total Liabilities (Millions of US $)
2022$33
2021$39
2020$57
2019$43
2018$19
2017$9
2016$9
2015$4
Corbus Pharmaceuticals Holdings, Inc. Quarterly Total Liabilities (Millions of US $)
2022-12-31$33
2021-12-31$39
2020-12-31$57
2019-12-31$43
2018-12-31$19
2017-12-31$9
2016-12-31$9
2015-12-31$4

Corbus Pharmaceuticals Holdings, Inc. Total Liabilities — FAQ

Corbus Pharmaceuticals Holdings, Inc. (CRBP) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRBP's total liabilities history?

The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s total liabilities by year and by quarter, including the growth rate.